Novo Nordisk Operating Income 2010-2024 | NVO

Novo Nordisk operating income for the twelve months ending June 30, 2024 was $16.179B, a 32.95% increase year-over-year.

  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
  • Novo Nordisk annual operating income for 2022 was $10.593B, a 13.53% increase from 2021.
  • Novo Nordisk annual operating income for 2021 was $9.33B, a 12.52% increase from 2020.

Novo Nordisk Operating Income 2010-2024 | NVO

  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
  • Novo Nordisk annual operating income for 2022 was $10.593B, a 13.53% increase from 2021.
  • Novo Nordisk annual operating income for 2021 was $9.33B, a 12.52% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M